Issue highlights—May 2023.
- Published in:
- Cytometry. Part B, 2023, v. 104, n. 3, p. 203, doi. 10.1002/cyto.b.22122
- By:
- Publication type:
- Article
Works matching IS 15524949 AND DT 2023 AND VI 104 AND IP 3
Results: 7
1
2
Increased IFN‐γ<sup>+</sup> and TNF‐α<sup>+</sup> mucosal‐associated invariant T cells in patients with aplastic anemia.
- Published in:
- Cytometry. Part B, 2023, v. 104, n. 3, p. 253, doi. 10.1002/cyto.b.22115
- By:
- Publication type:
- Article
3
Flow cytometric assessment for minimal/measurable residual disease in B lymphoblastic leukemia/lymphoma in the era of immunotherapy.
- Published in:
- Cytometry. Part B, 2023, v. 104, n. 3, p. 205, doi. 10.1002/cyto.b.22113
- By:
- Publication type:
- Article
4
The patterns and diagnostic significance of the lack of surface immunoglobulin light chain on mature B cells in clinical samples for lymphoma workup.
- Published in:
- Cytometry. Part B, 2023, v. 104, n. 3, p. 263, doi. 10.1002/cyto.b.22107
- By:
- Publication type:
- Article
5
Mature B‐ and plasma‐cell flow cytometric analysis: A review of the impact of targeted therapy.
- Published in:
- Cytometry. Part B, 2023, v. 104, n. 3, p. 224, doi. 10.1002/cyto.b.22097
- By:
- Publication type:
- Article
6
Issue Information.
- Published in:
- Cytometry. Part B, 2023, v. 104, n. 3, p. 197, doi. 10.1002/cyto.b.22075
- Publication type:
- Article
7
Abnormal B‐lymphoblasts in myelodysplastic syndromes and myeloproliferative neoplasms other than chronic myeloid leukemia.
- Published in:
- Cytometry. Part B, 2023, v. 104, n. 3, p. 243, doi. 10.1002/cyto.b.22047
- By:
- Publication type:
- Article